MedTrace Logo

Evaluation of the Effectiveness of Health Literacy Education Given to Women by Teach-Back Method

NCT07320079 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2026-01-14

No results posted yet for this study

Summary

This study aims to enhance women's health literacy levels and to examine the effectiveness of the teach-back teaching technique in improving women's health literacy. The research was designed as a randomized controlled study. In addition, this study aims to answer the question of whether health literacy education delivered using the teach-back method is effective in improving women's health literacy levels. Within the scope of the study, participants in the experimental group will receive health literacy education using the teach-back technique, while the control group will receive standard care. Data will be collected using a questionnaire method.

Conditions

  • Health Literacy
  • Teach Back

Interventions

OTHER

teach-back

The experimental group will receive face-to-face health literacy education using the teach-back method in six sessions, each lasting 45 minutes per week. The training will be provided by the researcher on a one-to-one basis. Health literacy education will be delivered using the teach-back method. After each session, participants will be asked to repeat what they have learned in their own words. The researcher will assess how well the participants have understood the topic. Any misunderstandings will be identified and corrected. During this process, participants will also have the opportunity to ask questions. Additional information will be provided if necessary until participants can accurately repeat the expected knowledge. The module will be considered complete once the participants have correctly expressed the information and understood the topic. The following week, the next module will begin, and this process will continue until all six modules are completed.

OTHER

Control Group

The control group will receive standard care

Sponsors & Collaborators

  • Istanbul University - Cerrahpasa

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2027-04-30
Completion
2027-07-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07320079 on ClinicalTrials.gov